Termination of Duties and Obligations. The Holders’ Representative’s duties and obligations under this Agreement shall survive until no CVRs remain outstanding or until this Agreement expires or is terminated pursuant to Section 7.7(b), whichever is earlier.
Appears in 5 contracts
Samples: Contingent Value Rights Agreement (Gemphire Therapeutics Inc.), Contingent Value Rights Agreement (Gemphire Therapeutics Inc.), Contingent Value Rights Agreement (GTX Inc /De/)
Termination of Duties and Obligations. The Holders’ Representative’s duties and obligations under this Agreement shall survive until no CVRs remain outstanding or until this Agreement expires or is terminated pursuant to Section 7.7(b)9.8, whichever is earlier.
Appears in 3 contracts
Samples: Contingent Value Rights Agreement (Aytu Bioscience, Inc), Agreement and Plan of Merger (Innovus Pharmaceuticals, Inc.), Contingent Value Rights Agreement (Aytu Bioscience, Inc)
Termination of Duties and Obligations. The Holders’ CVR Representative’s duties and obligations under this Agreement shall survive until no CVRs remain outstanding or until this Agreement expires or is terminated pursuant to Section 7.7(b)7.7, whichever is earlier.
Appears in 2 contracts
Samples: Contingent Value Rights Agreement (Rexahn Pharmaceuticals, Inc.), Contingent Value Rights Agreement (Rexahn Pharmaceuticals, Inc.)
Termination of Duties and Obligations. The Holders’ Holder Representative’s duties and obligations under this Agreement shall survive until no CVRs remain outstanding or until this Agreement expires or is terminated pursuant to Section 7.7(b)9.8, whichever is earlier.
Appears in 1 contract
Samples: Contingent Value Rights Agreement (Aadi Bioscience, Inc.)
Termination of Duties and Obligations. The Subject to Section 8.8, the Holders’ Representative’s duties and obligations under this Agreement shall survive until no CVRs remain outstanding or until this Agreement expires or is terminated pursuant to Section 7.7(b), whichever is earlieroutstanding.
Appears in 1 contract
Samples: Contingent Value Rights Agreement (Apricus Biosciences, Inc.)
